Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Free Cash Flow (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Free Cash Flow readings, the most recent being -$19.1 million for Q4 2025.

  • Quarterly Free Cash Flow fell 30.85% to -$19.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$82.2 million through Dec 2025, down 17.3% year-over-year, with the annual reading at -$82.2 million for FY2025, 17.3% down from the prior year.
  • Free Cash Flow hit -$19.1 million in Q4 2025 for Terns Pharmaceuticals, up from -$19.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$8.2 million in Q3 2021 and bottomed at -$24.4 million in Q1 2025.
  • Average Free Cash Flow over 5 years is -$15.6 million, with a median of -$14.5 million recorded in 2023.
  • The largest annual shift saw Free Cash Flow plummeted 85.82% in 2021 before it grew 24.67% in 2024.
  • Terns Pharmaceuticals' Free Cash Flow stood at -$10.9 million in 2021, then decreased by 3.46% to -$11.2 million in 2022, then plummeted by 72.17% to -$19.4 million in 2023, then grew by 24.67% to -$14.6 million in 2024, then crashed by 30.85% to -$19.1 million in 2025.
  • Per Business Quant, the three most recent readings for TERN's Free Cash Flow are -$19.1 million (Q4 2025), -$19.8 million (Q3 2025), and -$18.9 million (Q2 2025).